S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NYSE:STE

STERIS - STE Earnings Date, Estimates & Call Transcripts

$185.20
+3.78 (+2.08%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$180.94
$185.46
50-Day Range
$176.39
$220.86
52-Week Range
$159.21
$255.93
Volume
321,945 shs
Average Volume
593,943 shs
Market Capitalization
$18.39 billion
P/E Ratio
N/A
Dividend Yield
1.02%
Price Target
$232.83

Earnings Summary

Upcoming
Earnings Date
May. 10Estimated
Actual EPS
(Feb. 8)
$2.02 Missed By -$0.17
Consensus EPS
(Feb. 8)
$2.19
Last Year's Q1 EPS
(2/8/2022)
$2.12
Skip Charts & View Estimated and Actual Earnings Data

STE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

STE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

STERIS Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$1.86$1.86$1.86 
Q2 20231$1.95$1.95$1.95 
Q3 20231$2.17$2.17$2.17 
Q4 20231$2.16$2.16$2.16 
FY 20234$8.14$8.14 $8.14

STE Earnings Date and Information

STERIS last posted its earnings data on February 8th, 2023. The medical equipment provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.19 by $0.17. The company earned $1.22 billion during the quarter, compared to analyst estimates of $1.27 billion. Its revenue was up .8% on a year-over-year basis. STERIS has generated ($0.29) earnings per share over the last year (($0.29) diluted earnings per share). Earnings for STERIS are expected to grow by 8.94% in the coming year, from $8.05 to $8.77 per share. STERIS has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 10th, 2023 based off prior year's report dates.

STERIS Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2023
(Estimated)
        
2/8/2023Q3 23$2.19$2.02($0.17)$2.80$1.27 billion$1.22 billion    
11/9/2022Q2 2023$2.00$1.99($0.01)$7.13$1.22 billion$1.20 billion    
8/2/2022Q1 2023$1.90$1.90$2.70$1.23 billion$1.16 billion
5/11/2022Q4 2022$2.00$2.04+$0.04$3.56$1.18 billion$1.21 billion  
2/8/2022Q3 2022$1.95$2.12+$0.17$2.82$1.20 billion$1.20 billion    
11/2/20219/30/2021$1.82$1.99+$0.17$3.29$1.16 billion$1.20 billion    
8/9/20216/30/2021$1.49$1.76+$0.27$3.76$904.90 million$968.40 million    
5/18/20213/31/2021$1.80$1.63($0.17)$2.24$874.38 million$873.53 million  
2/2/202112/31/2020$1.52$1.73+$0.21$2.13$794.08 million$808.90 million  
11/2/20209/30/2020$1.27$1.48+$0.21$1.73$719.54 million$756.13 million  
8/3/20206/30/2020$0.98$1.31+$0.33$1.59$643.38 million$668.90 million  
5/13/2020Q4 20$1.57$1.64+$0.07$1.84$788.37 million$822.99 million  
2/10/2020Q3 20$1.42$1.45+$0.03$1.67$748.45 million$774.30 million  
11/4/2019Q2$1.26$1.32+$0.06$1.53$717.79 million$736.84 million  
8/5/2019Q1 2020$1.11$1.23+$0.12$1.47$674.12 million$696.80 million  
5/13/2019Q4 2019$1.44$1.53+$0.09$1.79$738.87 million$768.00 million  
2/11/201912/31/2018$1.26$1.26$1.96$687.90 million$696.24 million
11/6/20189/30/2018$1.08$1.10+$0.02$1.29$659.14 million$679.00 million  
8/8/2018Q1 2019$0.99$1.00+$0.01$1.18$638.63 million$638.76 million  
5/9/2018Q4 2018$1.22$1.24+$0.02$1.62$703.37 million$716.00 million  
2/7/2018Q3 2018$1.07$1.12+$0.05$1.13$663.17 million$661.90 million  
11/1/2017Q2 2018$0.95$0.94($0.01)$1.13$629.02 million$634.20 million
8/8/2017Q1 2018$0.80$0.85+$0.05$1.02$597.66 million$608.00 million  
5/9/2017Q4$1.07$1.11+$0.04$1.91$673.47 million$681.20 million  
2/7/2017Q3 2017$1.04$0.98($0.06)$2.02$680.13 million$646.80 million  
11/2/2016Q2 2017$0.90$0.89($0.01)$1.31$670.24 million$646.40 million
8/9/2016Q1 2017$0.78$0.79+$0.01$1.02$639.04 million$638.40 million  
5/18/2016Q4 2016$1.01$0.90($0.11)$1.13$701.92 million$690.30 million  
2/9/2016Q3 2016$0.94$0.98+$0.04$1.70$617.35 million$618.70 million
10/30/2015Q2 2016$0.76$0.83+$0.07$1.52$488.66 million$489.90 million  
8/4/2015Q1 2016$0.60$0.62+$0.02$0.84$439.23 million$439.90 million  
5/7/2015Q4 2015$0.89$0.98+$0.09$1.27$520.07 million$501.60 million  
2/4/2015Q3 2015$0.73$0.79+$0.06$0.95$475.22 million$473.20 million  
11/4/2014Q2 2015$0.62$0.68+$0.06$0.84$452.50 million$462.70 million  
8/5/2014Q1 2015$0.55$0.40($0.15)$0.39$418.26 million$412.60 million  
5/8/2014Q4 2014$0.87$0.91+$0.04$1.17$455.92 million$465.30 million  
2/5/2014Q3 2014$0.69$0.59($0.10)$0.70$406.40 million$405.60 million  
10/30/2013Q2 2014$0.55$0.55$0.60$376.82 million$383.80 million  
8/7/2013Q1 2014$0.56$0.44($0.12)$0.34$372.69 million$367.70 million  
5/7/2013Q4 2013$0.66$0.70+$0.04$0.70$405.79 million$426.20 million  
2/6/2013Q3 2013$0.56$0.58+$0.02$368.84 million$380.40 million  
10/31/2012Q213$0.52$0.53+$0.01$350.23 million$356.30 million  
8/2/2012$0.44$0.53+$0.09
5/8/2012$0.60$0.59($0.01)
2/7/2012$0.60$0.58($0.02)
11/2/2011$0.57$0.50($0.07)  
8/2/2011$0.50$0.46($0.04)
5/9/2011$0.62$0.61($0.01)  
2/8/2011$0.58$0.57($0.01)
11/3/2010Q2 2011$0.54$0.55+$0.01$0.50
8/3/2010Q1 2011$0.45$0.46+$0.01$1.68
5/6/2010Q4 2010$0.53$0.55+$0.02$0.60
2/2/2010Q3 2010$0.47$0.69+$0.22$0.69
11/3/2009Q2 2010$0.43$0.54+$0.11$0.54
7/30/2009Q1 2010$0.41$0.43+$0.02$0.43
5/7/2009Q4 2009$0.38$0.49+$0.11$0.51
1/27/2009Q3 2009$0.37$0.53+$0.16$0.58
10/30/2008Q2 2009$0.34$0.48+$0.14$0.48
7/30/2008Q1 2009$0.27$0.43+$0.16$0.43
5/7/2008Q4 2008$0.50$0.59+$0.09$0.76
1/30/2008Q3 2008$0.38$0.35($0.03)$0.36












STERIS Earnings - Frequently Asked Questions

When is STERIS's earnings date?

STERIS has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 10th, 2023 based off last year's report dates. Learn more on STE's earnings history.

Did STERIS beat their earnings estimates last quarter?

In the previous quarter, STERIS (NYSE:STE) missed the analysts' consensus estimate of $2.19 by $0.17 with a reported earnings per share (EPS) of $2.02. Learn more on analysts' earnings estimate vs. STE's actual earnings.

How can I listen to STERIS's earnings conference call?

The conference call for STERIS's latest earnings report can be listened to online. Listen to Conference Call

How can I read STERIS's conference call transcript?

The conference call transcript for STERIS's latest earnings report can be read online. Read Transcript

How much revenue does STERIS generate each year?

STERIS (NYSE:STE) has a recorded annual revenue of $4.59 billion.

How much profit does STERIS generate each year?

STERIS (NYSE:STE) has a recorded net income of $243.89 million. STE has generated -$0.29 earnings per share over the last four quarters.

What is STERIS's price-to-earnings ratio?

STERIS (NYSE:STE) has a forward price-to-earnings ratio of 23.01. The price/earnings-to-growth ratio is 2.05.

What is STERIS's EPS forecast for next year?

STERIS's earnings are expected to grow from $8.05 per share to $8.77 per share in the next year, which is a 8.94% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:STE) was last updated on 3/25/2023 by MarketBeat.com Staff